A Study Using a New Ultra-low Dose CT Scanner to Find Lung Nodules


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 14-002156
    Sponsor Protocol Number: 14-002156

About this study

The purpose of this study is to test the use of ultra-low dose CT scans to find lung nodules compared to the standard routine low dose CT scans.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria


Inclusion Criteria

  • Age18 to 99 years
  • Scheduled clinically-indicated low-dose chest CT scan for the purpose of nodule screening or follow-up
  • Initial scan is scheduled on a CT scanner at Mayo Clinic Rochester
  • Ability to provide written, informed consent


Exclusion Criteria 

  • Pregnancy
  • Patient already scheduled on new FORCE CT scanner
  • Patient scheduled to undergo low dose lung cancer screening

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Joel Fletcher, M.D.

Open for enrollment

Contact information:

Maria Shiung